Mycoplasma pneumoniae: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Typically | *Typically affects patients <40yo | ||
* | *Causes: | ||
** | **Pneumonia | ||
**[[Bullous myringitis]] - | **[[Bullous myringitis]] - painful, fluid filled vesicles on eardrum | ||
***Presence of otalgia should prompt evaluation | ***Presence of otalgia should prompt evaluation | ||
***Streptococcus pneumoniae is also associated w/ bullous myringitis | ***(Streptococcus pneumoniae is also associated w/ bullous myringitis) | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== |
Revision as of 04:25, 8 September 2015
Background
- Typically affects patients <40yo
- Causes:
- Pneumonia
- Bullous myringitis - painful, fluid filled vesicles on eardrum
- Presence of otalgia should prompt evaluation
- (Streptococcus pneumoniae is also associated w/ bullous myringitis)
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014